Cargando…
Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
Autores principales: | Wieser, Jill K., Kuehn, Gina J., Prezzano, James C., Cusick, Elizabeth H., Stiegler, Julia D., Scott, Glynis A., Liesveld, Jane L., Beck, Lisa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109361/ https://www.ncbi.nlm.nih.gov/pubmed/32258301 http://dx.doi.org/10.1016/j.jdcr.2020.02.030 |
Ejemplares similares
-
Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023) -
Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome
por: Du, Xiaoman, et al.
Publicado: (2022) -
A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab
por: Jiang, Xiaoyun, et al.
Publicado: (2023) -
Hypereosinophilic syndromes
por: Roufosse, Florence E, et al.
Publicado: (2007) -
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020)